Claritev Operating Income 2019-2025 | CTEV

Claritev operating income from 2019 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Claritev Annual Operating Income
(Millions of US $)
2024 $-1,390
2023 $162
2022 $-363
2021 $386
2020 $-132
2019 $368
2018 $428
Claritev Quarterly Operating Income
(Millions of US $)
2025-03-31 $10
2024-12-31 $-41
2024-09-30 $-338
2024-06-30 $-524
2024-03-31 $-486
2023-12-31 $41
2023-09-30 $40
2023-06-30 $35
2023-03-31 $47
2022-12-31 $-614
2022-09-30 $36
2022-06-30 $98
2022-03-31 $117
2021-12-31 $110
2021-09-30 $104
2021-06-30 $90
2021-03-31 $82
2020-12-31 $-40
2020-09-30 $-200
2020-06-30 $20
2020-03-31 $88
2019-12-31
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.717B $0.931B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.644B 58.07
Doximity (DOCS) United States $11.655B 53.96
Hims & Hers Health (HIMS) United States $11.295B 117.35
Tempus AI (TEM) United States $9.675B 0.00
IRhythm Technologies (IRTC) United States $4.275B 0.00
Inspire Medical Systems (INSP) United States $3.775B 58.99
Hinge Health (HNGE) United States $3.572B 0.00
Privia Health (PRVA) United States $2.516B 172.00
Enovis (ENOV) United States $1.765B 9.84
Phreesia (PHR) United States $1.591B 0.00
Clover Health Investments (CLOV) United States $1.517B 0.00
10x Genomics (TXG) United States $1.505B 0.00
Schrodinger (SDGR) United States $1.495B 0.00
Azenta (AZTA) United States $1.461B 67.89
Evolent Health (EVH) United States $1.335B 113.70
Omnicell (OMCL) United States $1.276B 22.51
Fulgent Genetics (FLGT) United States $0.550B 0.00
Veradigm (MDRX) United States $0.536B 0.00
Standard BioTools (LAB) United States $0.463B 0.00
Butterfly Network (BFLY) United States $0.435B 0.00
Talkspace (TALK) United States $0.420B 125.50
TruBridge (TBRG) United States $0.321B 713.00
Outset Medical (OM) United States $0.320B 0.00
Nyxoah SA (NYXH) Belgium $0.270B 0.00
Health Catalyst (HCAT) United States $0.260B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.231B 0.00
CapsoVision (CV) United States $0.213B 0.00
Zepp Health (ZEPP) Netherlands $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.136B 0.00
American Well (AMWL) United States $0.125B 0.00
EUDA Health Holdings (EUDA) Singapore $0.120B 0.00
Pulmonx (LUNG) United States $0.109B 0.00
MDxHealth SA (MDXH) Belgium $0.103B 0.00
CareCloud (CCLD) United States $0.098B 3.73
ImmunoPrecise Antibodies (IPA) Canada $0.083B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.080B 0.00
111 (YI) China $0.064B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
HeartBeam (BEAT) United States $0.042B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00